An EU-funded multi-partner international project led by Dr. Mark Tangney, from our Research Centre and Dr. Cormac Gahan, Alimentary Pharmabiotic Centre (APC), UCC, has been formally launched at Novartis Vaccines HQ in Siena Italy.
The four-year project is a collaboration between European universities and the pharmaceutical industry, and focuses on the development of new ways to visualise bacteria in the body. The work will take place at the Cork Cancer Research Centre; the Alimentary Pharmabiotic Centre at UCC; École Polytechnique Fédérale de Lausanne, Switzerland; and Novartis Vaccines, Siena, Italy by scientists from the fields of cancer research, immunology, microbiology, and chemistry.
The ‘Vaccines & Imaging Partnership’ (VIP) is an Industry-Academia Partnerships and Pathways (IAPP) project funded by the European Union under the FP7 Marie Curie Programme.
For further information, see http://www.vip-fp7.com